Ofatumumab for the treatment of chronic lymphocytic leukemia

ISSN： 1475-0708

Source： Therapy, Vol.6, Iss.4, 2009-07, pp. : 577-587

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 5, 2015-05 ,pp. : 417-421

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ofatumumab‐based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL)

CANCER, Vol. 119, Iss. 21, 2013-11 ,pp. : 3788-3796

John Wiley & Sons Inc

Access to resources Recommend Favorite

New oral small molecules in the treatment of chronic lymphocytic leukemia

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 1917-1926

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 5, 2015-05 ,pp. : 446-460

John Wiley & Sons Inc

Access to resources Recommend Favorite

State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia

Oncology Research and Treatment, Vol. 39, Iss. 1-2, 2016-0 ,pp. : 25-32

Karger

Access to resources Recommend Favorite